BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024 ...Middle East

SAN RAFAEL, Calif., Nov. 16, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced positive and consistent results from multiple real-world evidence studies of VOXZOGO® (vosoritide) in children with achondroplasia. These results, as well as data from the...

Read More Details
Finally We wish PressBee provided you with enough information of ( BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024 )

Also on site :

• '90s 'Dawson's Creek' Heartthrob, 53, Nearly Unrecognizable in 'Van Life' Video
• Why is Africa seeing a rise in mining accidents and exploitation?
• Awkward! Tom Brady Gets Booed At Indy 500